CNS Pharmaceuticals, Inc. Investing Cash Flow
CNS Pharmaceuticals, Inc. (CNSP) reported Investing Cash Flow of -$10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$3.82K.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$6.18K.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$18.18K.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$4.19K.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$3.90K.
- CNS Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$4.42K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$10.00K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$6.18K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$18.18K 10-K · filed 2026-03-31 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | -$4.19K derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$4.19K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$4.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.19K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |||
| 2023-12-31 | -$2.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.90K derived: sum of 2 quarters · filed 2025-03-31 | -$3.90K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.74K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.51K derived: sum of 2 quarters · filed 2024-04-01 | -$4.42K derived: sum of 3 quarters · filed 2024-04-01 | -$4.42K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$1.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.42K derived: sum of 2 quarters · filed 2023-11-14 | -$4.42K 10-Q · filed 2023-11-14 | -$6.50K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$2.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.91K 10-Q · filed 2023-08-14 | -$4.99K derived: sum of 3 quarters · filed 2023-08-14 | -$4.99K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | -$2.08K derived: sum of 2 quarters · filed 2023-03-31 | -$2.08K derived: sum of 3 quarters · filed 2023-03-31 | -$2.08K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | -$2.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.08K derived: sum of 2 quarters · filed 2023-03-31 | -$2.08K derived: sum of 3 quarters · filed 2023-03-31 | -$5.75K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | -$3.67K 10-Q · filed 2022-11-10 | -$3.67K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$3.67K 10-Q · filed 2022-08-12 | -$3.67K derived: sum of 3 quarters · filed 2022-08-12 | -$3.67K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$3.67K 10-Q · filed 2022-05-13 | -$3.67K derived: sum of 2 quarters · filed 2022-05-13 | -$3.67K derived: sum of 3 quarters · filed 2022-05-13 | -$15.21K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | -$11.54K derived: sum of 3 quarters · filed 2022-03-03 | -$17.95K 10-K · filed 2022-03-03 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$11.54K derived: sum of 2 quarters · filed 2021-11-12 | -$17.95K 10-Q · filed 2021-11-12 | -$29.69K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$11.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$17.95K 10-Q · filed 2021-08-13 | -$29.69K derived: sum of 3 quarters · filed 2021-08-13 | -$29.69K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$6.41K 10-Q · filed 2021-05-13 | -$18.15K derived: sum of 2 quarters · filed 2021-05-13 | -$18.15K derived: sum of 3 quarters · filed 2021-05-13 | -$26.53K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$11.74K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$11.74K derived: sum of 2 quarters · filed 2021-02-12 | -$20.12K derived: sum of 3 quarters · filed 2021-02-12 | -$20.12K 10-K · filed 2021-02-12 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$8.38K derived: sum of 2 quarters · filed 2020-11-12 | -$8.38K 10-Q · filed 2020-11-12 | -$8.38K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$8.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$8.38K 10-Q · filed 2020-08-10 | -$8.38K derived: sum of 3 quarters · filed 2020-08-10 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |